A process is disclosed for screening substances having a modulating effect on the interleukine-5-receptor-dependent signal tranmission path in mammal cells. Test substances are applied on cells which express the functional interleukine-5-receptor and are transformed with a recombinant DNA containing a reporter gene and a regulatory sequence functionally linked thereto which is sensitive to a change in concentration of a secondary messenger substance of the interleukine-5- receptor-dependent signal transmission path. Substances specific to the interleukine-5- receptor-dependent signal transmission path and with potential pharmacological effect may be identified by this process.
展开▼